AMP-activated protein kinase: role in metabolism and therapeutic implications
AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and i...
Gespeichert in:
Veröffentlicht in: | Diabetes, obesity & metabolism obesity & metabolism, 2006-11, Vol.8 (6), p.591-602 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 602 |
---|---|
container_issue | 6 |
container_start_page | 591 |
container_title | Diabetes, obesity & metabolism |
container_volume | 8 |
creator | Schimmack, Greg DeFronzo, Ralph A. Musi, Nicolas |
description | AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases. |
doi_str_mv | 10.1111/j.1463-1326.2005.00561.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68932924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68932924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</originalsourceid><addsrcrecordid>eNqNkMlOwzAQhi0EYim8AsqJW4K3xAniUlEoS8siQBwtx5kKt1lK7EL79riLyhVLlsfy_81YH0IBwRHx63wcEZ6wkDCaRBTjOPI7IdF8Bx1uH3ZXNQ3TDNMDdGTtGGPMWSr20QERmCY8ZYdo2B0-h0o7860cFMG0bRyYOpiYWlm4CNqmhMDfK3Aqb0pjq0DVReA-oVVTmDmjA1NNS6OVM01tj9HeSJUWTjZnB73fXL9d3YaDp_7dVXcQai4wCVOVFYXIYkpwLkBlOSGxKkY65jEVDIjSQARllOOECC10BjkpcKETzLNRnmrWQWfrvv6_XzOwTlbGaihLVUMzszJJM0Yzyn0wXQd121jbwkhOW1OpdiEJlkuVciyXxuTSmFyqlCuVcu7R082MWV5B8Qdu3PnA5TrwY0pY_Lux7D0NfeHxcI0b62C-xVU7kYlgIpYfj315__I26PHXvnxgv_xakUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68932924</pqid></control><display><type>article</type><title>AMP-activated protein kinase: role in metabolism and therapeutic implications</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Schimmack, Greg ; DeFronzo, Ralph A. ; Musi, Nicolas</creator><creatorcontrib>Schimmack, Greg ; DeFronzo, Ralph A. ; Musi, Nicolas</creatorcontrib><description>AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.</description><identifier>ISSN: 1462-8902</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/j.1463-1326.2005.00561.x</identifier><identifier>PMID: 17026483</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>ACC ; AMP-Activated Protein Kinases ; AMPK ; Blood Glucose - metabolism ; Diabetes Mellitus, Type 2 - physiopathology ; exercise ; Exercise - physiology ; glucose transport ; Heart Diseases - enzymology ; Humans ; Hypoglycemic Agents - pharmacology ; Lipid Metabolism - physiology ; Liver - metabolism ; Multienzyme Complexes - drug effects ; Multienzyme Complexes - physiology ; Muscle, Skeletal - enzymology ; Protein-Serine-Threonine Kinases - drug effects ; Protein-Serine-Threonine Kinases - physiology ; type 2 diabetes mellitus</subject><ispartof>Diabetes, obesity & metabolism, 2006-11, Vol.8 (6), p.591-602</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</citedby><cites>FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1463-1326.2005.00561.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1463-1326.2005.00561.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17026483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schimmack, Greg</creatorcontrib><creatorcontrib>DeFronzo, Ralph A.</creatorcontrib><creatorcontrib>Musi, Nicolas</creatorcontrib><title>AMP-activated protein kinase: role in metabolism and therapeutic implications</title><title>Diabetes, obesity & metabolism</title><addtitle>Diabetes Obes Metab</addtitle><description>AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.</description><subject>ACC</subject><subject>AMP-Activated Protein Kinases</subject><subject>AMPK</subject><subject>Blood Glucose - metabolism</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>exercise</subject><subject>Exercise - physiology</subject><subject>glucose transport</subject><subject>Heart Diseases - enzymology</subject><subject>Humans</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Lipid Metabolism - physiology</subject><subject>Liver - metabolism</subject><subject>Multienzyme Complexes - drug effects</subject><subject>Multienzyme Complexes - physiology</subject><subject>Muscle, Skeletal - enzymology</subject><subject>Protein-Serine-Threonine Kinases - drug effects</subject><subject>Protein-Serine-Threonine Kinases - physiology</subject><subject>type 2 diabetes mellitus</subject><issn>1462-8902</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMlOwzAQhi0EYim8AsqJW4K3xAniUlEoS8siQBwtx5kKt1lK7EL79riLyhVLlsfy_81YH0IBwRHx63wcEZ6wkDCaRBTjOPI7IdF8Bx1uH3ZXNQ3TDNMDdGTtGGPMWSr20QERmCY8ZYdo2B0-h0o7860cFMG0bRyYOpiYWlm4CNqmhMDfK3Aqb0pjq0DVReA-oVVTmDmjA1NNS6OVM01tj9HeSJUWTjZnB73fXL9d3YaDp_7dVXcQai4wCVOVFYXIYkpwLkBlOSGxKkY65jEVDIjSQARllOOECC10BjkpcKETzLNRnmrWQWfrvv6_XzOwTlbGaihLVUMzszJJM0Yzyn0wXQd121jbwkhOW1OpdiEJlkuVciyXxuTSmFyqlCuVcu7R082MWV5B8Qdu3PnA5TrwY0pY_Lux7D0NfeHxcI0b62C-xVU7kYlgIpYfj315__I26PHXvnxgv_xakUg</recordid><startdate>200611</startdate><enddate>200611</enddate><creator>Schimmack, Greg</creator><creator>DeFronzo, Ralph A.</creator><creator>Musi, Nicolas</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200611</creationdate><title>AMP-activated protein kinase: role in metabolism and therapeutic implications</title><author>Schimmack, Greg ; DeFronzo, Ralph A. ; Musi, Nicolas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4701-8a9dd795210b7ea9b115adfc545273e1ace1723240617c7c9eb1d0dc6049fb8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ACC</topic><topic>AMP-Activated Protein Kinases</topic><topic>AMPK</topic><topic>Blood Glucose - metabolism</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>exercise</topic><topic>Exercise - physiology</topic><topic>glucose transport</topic><topic>Heart Diseases - enzymology</topic><topic>Humans</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Lipid Metabolism - physiology</topic><topic>Liver - metabolism</topic><topic>Multienzyme Complexes - drug effects</topic><topic>Multienzyme Complexes - physiology</topic><topic>Muscle, Skeletal - enzymology</topic><topic>Protein-Serine-Threonine Kinases - drug effects</topic><topic>Protein-Serine-Threonine Kinases - physiology</topic><topic>type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schimmack, Greg</creatorcontrib><creatorcontrib>DeFronzo, Ralph A.</creatorcontrib><creatorcontrib>Musi, Nicolas</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schimmack, Greg</au><au>DeFronzo, Ralph A.</au><au>Musi, Nicolas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AMP-activated protein kinase: role in metabolism and therapeutic implications</atitle><jtitle>Diabetes, obesity & metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2006-11</date><risdate>2006</risdate><volume>8</volume><issue>6</issue><spage>591</spage><epage>602</epage><pages>591-602</pages><issn>1462-8902</issn><eissn>1463-1326</eissn><abstract>AMP‐activated protein kinase (AMPK) is an enzyme that works as a fuel gauge which becomes activated in situations of energy consumption. AMPK functions to restore cellular ATP levels by modifying diverse metabolic and cellular pathways. In the skeletal muscle, AMPK is activated during exercise and is involved in contraction‐stimulated glucose transport and fatty acid oxidation. In the heart, AMPK activity increases during ischaemia and functions to sustain ATP, cardiac function and myocardial viability. In the liver, AMPK inhibits the production of glucose, cholesterol and triglycerides and stimulates fatty acid oxidation. Recent studies have shown that AMPK is involved in the mechanism of action of metformin and thiazolidinediones, and the adipocytokines leptin and adiponectin. These data, along with evidence that pharmacological activation of AMPK in vivo improves blood glucose homeostasis, cholesterol concentrations and blood pressure in insulin‐resistant rodents, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes, ischaemic heart disease and other metabolic diseases.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17026483</pmid><doi>10.1111/j.1463-1326.2005.00561.x</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-8902 |
ispartof | Diabetes, obesity & metabolism, 2006-11, Vol.8 (6), p.591-602 |
issn | 1462-8902 1463-1326 |
language | eng |
recordid | cdi_proquest_miscellaneous_68932924 |
source | MEDLINE; Access via Wiley Online Library |
subjects | ACC AMP-Activated Protein Kinases AMPK Blood Glucose - metabolism Diabetes Mellitus, Type 2 - physiopathology exercise Exercise - physiology glucose transport Heart Diseases - enzymology Humans Hypoglycemic Agents - pharmacology Lipid Metabolism - physiology Liver - metabolism Multienzyme Complexes - drug effects Multienzyme Complexes - physiology Muscle, Skeletal - enzymology Protein-Serine-Threonine Kinases - drug effects Protein-Serine-Threonine Kinases - physiology type 2 diabetes mellitus |
title | AMP-activated protein kinase: role in metabolism and therapeutic implications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A08%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AMP-activated%20protein%20kinase:%20role%20in%20metabolism%20and%20therapeutic%20implications&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Schimmack,%20Greg&rft.date=2006-11&rft.volume=8&rft.issue=6&rft.spage=591&rft.epage=602&rft.pages=591-602&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/j.1463-1326.2005.00561.x&rft_dat=%3Cproquest_cross%3E68932924%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68932924&rft_id=info:pmid/17026483&rfr_iscdi=true |